SBRA Stock Analysis: Buy, Sell, or Hold?
SBRA - Sabra Healthcare REIT, Inc.
$20.16
0.48 (2.44%)
▲
5d:
+4.4%
30d:
+8.56%
90d:
+3.44%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 03, 2026
29d
Get Alerted When SBRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SBRA shows positive signals but monitor for confirmation. Market pricing in 1.8% growth. Moderate conviction.
💡 BUY OPPORTUNITY: SBRA shows positive signals but monitor for confirmation. Market pricing in 1.8% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.58
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$16.50
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBRA is currently trading at $20.16, which is considered extended relative to its 30-day fair value range of $18.21 to $19.82. The stock's valuation (Forward PE: 27.1) is in line with its historical norms (25.7). At these levels, the market is pricing in 1.8% annual earnings growth.
Technical Outlook: Technically, SBRA is in a strong uptrend. Immediate support is located at $17.54, while resistance sits at $20.78.
Market Sentiment: SBRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SBRA is in a strong uptrend. Immediate support is located at $17.54, while resistance sits at $20.78.
Market Sentiment: SBRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.21 -
$19.82
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($22.15)
- BULLISH: Expecting earnings turnaround to 1.8% growth with 21.7% revenue growth
Trading Range Analysis
30-Day Trading Range
$18.21 -
$19.82
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.54
Resistance Level
$20.78
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.12
Wall Street Target
$22.15
(+9.9%)
Revenue Growth (YoY)
21.7%
Earnings Growth (YoY)
-5.6%
Profit Margin
19.1%
Valuation Premium vs History
+1.8% premium
PE vs Historical
27.1 vs 25.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.8%
(market-implied from PE analysis)
1-Year Target
$20.52
(+2%)
2-Year Target
$20.89
(+4%)
3-Year Target
$21.27
(+6%)
3-Yr Target (if PE normalizes)
(PE: 27→26)
PE COMPRESSION
$20.15
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.1, Growth: 10.9%)
$27.53
(+37%)
Base:
(SPY PE: 21.8, Growth: 10.9%)
$22.10
(+10%)
Bear:
(PE: 18.5, Growth: 10.9%)
$18.79
(-7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Trailing PE: 31.24 | Current EPS (TTM): $0.63
Bull Case
$25.54
(+27%)
Analyst growth 18.0%, PE expands to 34.4
Base Case
$23.22
(+15%)
Market implied 18.0%, PE stable at 31.2
Bear Case
$13.38
(-34%)
Severe decline -20.0%, PE contracts to 26.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 7:47 PM ET
Data refreshes hourly during market hours. Next update: 8:47 PM
Data refreshes hourly during market hours. Next update: 8:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$97 | 62 BUY |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$235 | 59 HOLD |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$21 | 61 BUY |
|
AHR
American Healthcare REIT… |
STRONG BUY
9 analysts |
$58 | 62 BUY |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$15 | 60 HOLD |
